Use of Warfarin or Direct Oral Anticoagulants and Risk of Prostate Cancer in PCBaSe: A Nationwide Case-Control Study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Use of Warfarin or Direct Oral Anticoagulants and Risk of Prostate Cancer in PCBaSe: A Nationwide Case-Control Study

Published:2020-10-08 Issue: Volume:10 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

Parker Jonathan,Crawley Danielle,Garmo Hans,Lindahl Bertil,Styrke Johan,Adolfsson Jan,Lambe Mats,Stattin Pär,Van Hemelrijck Mieke,Beckmann Kerri

Funder

Svenska Forskningsrådet Formas

Cancerföreningen i Stockholm

Swedish Cancer Foundation

National Health and Medical Research Council

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference35 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J Clin.,2018

2. Epidemiology of prostate cancer;Rawla;World J Oncol.,2019

3. Oral anticoagulation with vitamin K inhibitors and determinants of successful self-management in primary care;Tamayo Aguirre;BMC Cardiovasc Disord.,2016

4. Incidence of cancer after prophylaxis with warfarin against recurrent venous thromboembolism. Duration of anticoagulation trial;Schulman;N Engl J Med.,2000

5. The association between vitamin K antagonist therapy and site-specific cancer incidence estimated by using heart valve replacement as an instrumental variable;Ahern;Am J Epidemiol.,2011

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of a Novel Bloom’s Syndrome Protein (BLM) Inhibitor Suppressing Growth and Metastasis of Prostate Cancer;International Journal of Molecular Sciences;2022-11-26

2. New insights into vitamin K biology with relevance to cancer;Trends in Molecular Medicine;2022-10

3. The impact of warfarin on overall survival in cancer patients;Thrombosis Research;2021-11

4. The Value of Real-World Data in Understanding Prostate Cancer Risk and Improving Clinical Care: Examples from Swedish Registries;Cancers;2021-02-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3